image
Financial Services - Asset Management - NASDAQ - US
$ 15.04
-0.54 %
$ 557 M
Market Cap
11.0
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CCAP stock under the worst case scenario is HIDDEN Compared to the current market price of 15 USD, Crescent Capital BDC, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CCAP stock under the base case scenario is HIDDEN Compared to the current market price of 15 USD, Crescent Capital BDC, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CCAP stock under the best case scenario is HIDDEN Compared to the current market price of 15 USD, Crescent Capital BDC, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CCAP

image
$20.0$20.0$19.0$19.0$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.015 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
142 M REVENUE
-3.32%
74.7 M OPERATING INCOME
-11.14%
73.6 M NET INCOME
-12.15%
58.9 M OPERATING CASH FLOW
-36.18%
-23.8 M INVESTING CASH FLOW
0.00%
-43.5 M FINANCING CASH FLOW
48.85%
42.1 M REVENUE
58.92%
0 OPERATING INCOME
0.00%
16.6 M NET INCOME
0.00%
-15.1 M OPERATING CASH FLOW
-423.64%
-26.6 M INVESTING CASH FLOW
-25.45%
6.34 M FINANCING CASH FLOW
27.66%
Balance Sheet Crescent Capital BDC, Inc.
image
Current Assets 22.3 M
Cash & Short-Term Investments 10.1 M
Receivables 12.2 M
Other Current Assets 0
Non-Current Assets 1.65 B
Long-Term Investments 1.6 B
PP&E 0
Other Non-Current Assets 42.5 M
96.12 %Total Assets$1.7b
Current Liabilities 26 M
Accounts Payable 26 M
Short-Term Debt 0
Other Current Liabilities 0
Non-Current Liabilities 890 M
Long-Term Debt 876 M
Other Non-Current Liabilities 13.8 M
2.84 %95.65 %Total Liabilities$915.6m
EFFICIENCY
Earnings Waterfall Crescent Capital BDC, Inc.
image
Revenue 142 M
Cost Of Revenue 58.9 M
Gross Profit 83.5 M
Operating Expenses 8.76 M
Operating Income 74.7 M
Other Expenses 1.09 M
Net Income 73.6 M
160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m00142m(59m)84m(9m)75m(1m)74mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
58.63% GROSS MARGIN
58.63%
52.47% OPERATING MARGIN
52.47%
51.71% NET MARGIN
51.71%
9.94% ROE
9.94%
4.45% ROA
4.45%
4.48% ROIC
4.48%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Crescent Capital BDC, Inc.
image
100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 73.6 M
Depreciation & Amortization 0
Capital Expenditures 0
Stock-Based Compensation 0
Change in Working Capital 2.5 M
Others -16.4 M
Free Cash Flow 58.9 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Crescent Capital BDC, Inc.
image
Wall Street analysts predict an average 1-year price target for CCAP of $17.1 , with forecasts ranging from a low of $15 to a high of $19 .
CCAP Lowest Price Target Wall Street Target
15 USD -0.27%
CCAP Average Price Target Wall Street Target
17.1 USD 13.70%
CCAP Highest Price Target Wall Street Target
19 USD 26.33%
Price
Max Price Target
Min Price Target
Average Price Target
2020191918181717161615151414Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
0.44% DIVIDEND YIELD
0.05 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.801.801.601.601.401.401.201.201.001.000.800.800.600.600.400.400.200.200.000.000.410.410.410.410.10.410.420.410.410.410.410.110.420.420.410.410.410.080.410.090.420.411.641.280.410.560.411.640.090.990.411.030.070.990.420.940.89202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership Crescent Capital BDC, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
2 BDCs With 20%+ Discounts, 1 To Buy And 1 To Avoid BDCs have entered a challenging period. This is why the market has assigned notable discounts across the board. Some BDCs have become very deeply discounted. seekingalpha.com - 1 week ago
Warning To All BDC Investors I am increasingly cautious on BDCs due to rising non-accruals, weaker earnings, and looser underwriting amid intense competition for private credit deals. Elevated interest rates are suppressing BDC valuations and making it harder for borrowers to service debt, leading to fewer quality investment opportunities. Dividend coverage is weakening across many BDCs, with higher non-accruals and PIK income threatening the sustainability of distributions investors rely on. seekingalpha.com - 2 weeks ago
Crescent Capital: 11% Yield And Fire Sale Price Make It A Buy Crescent Capital BDC offers a compelling 10.9% dividend yield and trades at a 22% discount to NAV, providing a strong margin of safety. Recent headwinds, including lower NII and some non-accruals, are largely priced in, with the portfolio remaining healthy and well-protected by first-lien debt. Management's confidence is evident through continued regular dividends and two special dividends, signaling belief in near-term NII recovery. seekingalpha.com - 3 weeks ago
Crescent Capital BDC: NAV Decline Continues Following Q1 Earnings Crescent Capital BDC trades at a significant discount to NAV and offers a high 12.5% yield, but recent performance and total returns have been weak. Rising non-accruals, declining earnings, and weakening distribution coverage raise concerns about portfolio health and dividend sustainability. While the portfolio is diversified and focused on first lien, floating rate debt, higher interest rates are pressuring borrowers and increasing risks. seekingalpha.com - 3 weeks ago
Crescent Capital BDC: Latest Quarter A Clear Sign Of A Weakening Economy (Rating Downgrade) I'm downgrading Crescent Capital from buy to hold due to weakening fundamentals and rising economic uncertainty. Recent earnings showed sequential declines in total and net investment income, with increasing non-accruals and NAV erosion. CCAP's leverage is above peer average, raising risk, and the probability of a dividend cut is higher if economic conditions worsen. seekingalpha.com - 3 weeks ago
New Strong Sell Stocks for May 19th BOOT, CCAP and HP have been added to the Zacks Rank #5 (Strong Sell) List on May 19, 2025. zacks.com - 4 weeks ago
Crescent Capital BDC, Inc. (CCAP) Q1 2025 Earnings Conference Call Transcript Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q1 2025 - Earnings Conference Call May 15, 2025 12:00 PM ET Company Participants Dan McMahon - Head, IR Jason Breaux - CEO Henry Chung - President Gerhard Lombard - CFO Conference Call Participants Paul Johnson - KBW Robert Dodd - Raymond James Finian O'Shea - Wells Fargo Mickey Schleien - Ladenburg Thalmann Operator Good morning, and welcome to Crescent Capital BDC, Inc. First Quarter Ended March 31, 2025 Earnings Conference Call. Please note that Crescent Capital BDC, Inc. may be referred to as CCAP, Crescent BDC or the company throughout the call. seekingalpha.com - 1 month ago
Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Lag Estimates Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.63 per share a year ago. zacks.com - 1 month ago
Crescent Capital BDC, Inc. Reports First Quarter 2025 Earnings Results; Declares a Second Quarter Base Dividend of $0.42 Per Share LOS ANGELES, May 14, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.45 per share and net income of $0.11 per share, for the quarter ended March 31, 2025. Net asset value (NAV) per share was $19.62 at March 31, 2025 compared to $19.98 as of December 31, 2024. globenewswire.com - 1 month ago
My Income Portfolio: In The Garden Of Eden Total Return can be misleading if not supported by NAV growth, as it may include unsustainable distributions and Return of Capital. Behavioral finance shows markets are irrational, making it crucial to consider practical aspects beyond theoretical Total Return calculations. I believe that NAV performance can affect our discretion in the reinvestment choices for the distributions we receive from our savings much more than Total Return. seekingalpha.com - 1 month ago
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2025 Financial Results LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the first quarter ended March 31, 2025 on Wednesday, May 14, 2025 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, May 15, 2025 at 12:00 p.m. Eastern Time to discuss its first quarter ended March 31, 2025 financial results. globenewswire.com - 1 month ago
I'm Buying 2 Income Machines With 5-12% Yields Spring is an ideal time for income investors to revisit portfolios, focusing on quality stocks like Crescent Capital BDC and Federal Realty Trust. Crescent Capital BDC offers a 12.4% yield, strong dividend coverage, and a diversified, conservatively managed portfolio, trading at a 24% discount to NAV. Federal Realty Investment Trust has a 57-year dividend growth streak, high-quality retail assets, and a 4.8% yield, trading well below historical valuation norms. seekingalpha.com - 1 month ago
8. Profile Summary

Crescent Capital BDC, Inc. CCAP

image
COUNTRY US
INDUSTRY Asset Management
MARKET CAP $ 557 M
Dividend Yield 0.44%
Description Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Contact 11100 Santa Monica Boulevard, Los Angeles, CA, 90025 https://www.crescentbdc.com
IPO Date Feb. 3, 2020
Employees None
Officers Mr. Henry Sahn Chung President Mr. Jason A. Breaux Chief Executive Officer Mr. Gerhard Pieter Lombard Chief Financial Officer Mr. Raymond Feliciano Barrios Managing Director Mr. Erik George Barrios Chief Compliance Officer Mr. Daniel McMahon Senior Vice President & Head of Public Investor Relations Mr. George Paul Hawley J.D. Secretary & General Counsel Mr. Kirill S. Bouek Controller